Dechert Advises Cathay Capital in the Sale of the Cenexi Group
Dechert advised Cathay Capital, a global investment firm, in connection with the sale of the Cenexi group to the Indian group Gland Pharma, controlled by the Chinese conglomerate Fosun.
Cenexi is a French CDMO specialized in the manufacture of sterile and injectable pharmaceutical products.
The completion of the sale is subject to the receipt of the necessary regulatory approvals.
Dechert’s M&A team was composed of Alain Decombe, partner, Vianney Toulouse and Dahila Ibourichene, associates. Antitrust partner Laurence Bary; regulatory partner Sophie Pelé; and labor national partner Thibault Meiers were also involved.
Dechert is a leading global law firm with 21 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.